Triastek Inc., an expert in 3D printing pharmaceuticals, has entered into a research collaboration and platform technology license agreement with BioNTech SE, an immunotherapy company focusing on novel therapies for cancer and other serious diseases.
Under the agreement, the companies will develop RNA therapeutics for oral delivery based on 3D printing. The collaboration aims to provide therapies to address unmet medical needs in an easy-to-administer oral formulation.
Triastek will bring to the table its expertise in oral tablet designs made possible by 3D printing aimed at optimizing the delivery of RNA therapeutics across the gastrointestinal mucosa, minimizing degradation in the gastrointestinal tract, and delivering RNA therapeutics to the portion of the gastrointestinal tract where absorption will potentially be the greatest. Triastek’s ability to create tablet structures with unique external and internal tablet geometries, including multiple-layer and multi-compartment designs, will be leveraged, aiming to optimize the delivery of RNA therapeutics.
“We are immensely honored to announce our collaboration with BioNTech, a leader in revolutionizing patient care with transformative medicines,” stated Dr. Senping Cheng, Founder, and CEO of Triastek. “We believe this collaboration stands as a promising milestone in advancing oral RNA therapeutics using 3D printing technology and aims to set new benchmarks in the development of large molecule oral drugs. We are committed to working diligently together to make breakthroughs in oral delivery of RNA therapeutics.”
Under the terms of the agreement, Triastek will receive an upfront payment of $10 million, and will be eligible to receive development, regulatory and commercial milestone payments potentially totaling over $1.2 billion as well as tiered royalties on potential future product sales.
Remember, you can post job opportunities in the AM Industry on 3D ADEPT Media free of charge or look for a job via our job board. Make sure to follow us on our social networks and subscribe to our weekly newsletter : Facebook, Twitter, LinkedIn & Instagram! If you want to be featured in the next issue of our digital magazine or if you hear a story that needs to be heard, make sure to send it to contact@3dadept.com